Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT05805943 · UNKNOWN
Trial details
- NCT number
- NCT05805943
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-02
- Primary completion
- 2025-05-25
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.